[Atenolol in treatment of patients with airway obstruction].

[Atenolol in treatment of patients with airway obstruction].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego (1996-12-01)

R Chazan

ABSTRAKT

It is well known that beta-2-blockers are contraindicated for patients with bronchial hyperactivity. Author discusses the clinical observations in relation to treatment with atenolol in circulatory system pathology.

MATERIAŁY

Numer produktu

Marka

Opis produktu

A1340000

Atenolol, European Pharmacopoeia (EP) Reference Standard

1044403

USP

Atenolol, United States Pharmacopeia (USP) Reference Standard

A-072

Supelco

Atenolol solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant^®

A7655

Sigma-Aldrich

Atenolol, ≥98% (TLC), powder